Shaanxi Meibang Pharmaceutical Group Co., Ltd. (SHA:605033)

China · Delayed Price · Currency is CNY

19.15

-0.44 (-2.25%)

Aug 17, 2026, 3:00 PM CST

SHA:605033 Financials Overview

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	981.56	911.95	885.53	699.03	906.05	842.49
Revenue Growth	13.97%	2.98%	26.68%	-22.85%	7.54%	48.19%
Gross Profit	334.29	292.75	231.39	220.99	377.23	310.11
Operating Income	67.71	42.4	18.88	42.9	134.57	123.06
Net Income	63.59	48.66	36.86	57.56	145.09	125.74
Earnings Per Share	0.47	0.36	0.27	0.43	1.07	1.14
EPS Growth	149.14%	33.33%	-37.21%	-59.81%	-6.14%	46.15%

Revenue by Segment

Fiscal Year	FY 2025
Period Ending	Dec '25 Dec 31, 2025
Fungicide	539.64
Insecticides	261.94
Others	107.25
Total	908.84

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	376.24	764.11	656.33	481.17	399.68	402.39
Total Debt	158.21	150.66	73.08	1	-	27.05
Net Cash (Debt)	218.03	613.45	583.25	480.17	399.68	375.34
Net Cash Growth	-17.53%	5.18%	21.47%	20.14%	6.49%	88.22%
Net Cash Per Share	1.61	4.54	4.27	3.59	2.95	3.40

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	114.48	229.36	280.4	334.79	126.41	-108.75
Capital Expenditures	-147.21	-184.63	-158.81	-203.69	-109.29	-106.53
Free Cash Flow	-32.73	44.74	121.59	131.1	17.12	-215.28
Free Cash Flow Growth	-	-63.21%	-7.26%	665.68%	-	-

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	34.06%	32.10%	26.13%	31.61%	41.63%	36.81%
Operating Margin	6.90%	4.65%	2.13%	6.14%	14.85%	14.61%
Pretax Margin	7.76%	5.74%	4.28%	8.93%	16.82%	16.48%
Profit Margin	6.48%	5.34%	4.16%	8.23%	16.01%	14.92%
FCF Margin	-3.33%	4.91%	13.73%	18.75%	1.89%	-25.55%

Dividends

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 17, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Dividend Per Share	0.150	0.150	0.145	0.150	0.220	0.190
Dividend Per Share Growth	3.45%	3.45%	-3.33%	-31.82%	15.79%	-
Dividend Yield	0.77%	0.75%	1.22%	0.86%	1.34%	0.75%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 17, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	40.79	55.79	44.13	42.16	16.26	28.72
P/FCF Ratio	-	60.69	13.38	18.51	137.78	-
PS Ratio	2.64	2.98	1.84	3.47	2.60	4.29